RESUMEN
The human PRODH gene has been shown to have unique roles in regulating cell survival and apoptotic pathways and it has been related to velocardiofacial syndrome/DiGeorge syndrome and increased susceptibility to schizophrenia. It encodes for the flavoprotein proline oxidase (PO), which catalyzes the conversion of l-proline to Δ(1)-pyrroline-5-carboxylate. Despite the important physiological and medical interest in human PO, up to now only microbial homologues of PO have been expressed as recombinant protein and fully characterized. By using a bioinformatics analysis aimed at identifying the catalytic domain and the regions with a high intrinsic propensity to structural disorder, we designed deletion variants of human PO that were successfully expressed in Escherichia coli as soluble proteins in fairly high amounts (up to 10mg/L of fermentation broth). The His-tagged PO-barrelN protein was isolated as an active (the specific activity is 0.032U/mg protein), dimeric holoenzyme showing the typical spectral properties of FAD-containing flavoprotein oxidases. These results pave the way for elucidating structure-function relationships of this human flavoenzyme and clarifying the effect of the reported polymorphisms associated with disease states.
Asunto(s)
Fragmentos de Péptidos/biosíntesis , Prolina Oxidasa/biosíntesis , Proteínas Recombinantes de Fusión/biosíntesis , Secuencia de Aminoácidos , Secuencia de Bases , Dominio Catalítico , Cromatografía de Afinidad , Clonación Molecular , Escherichia coli , Expresión Génica , Humanos , Cinética , Datos de Secuencia Molecular , Fragmentos de Péptidos/química , Fragmentos de Péptidos/aislamiento & purificación , Prolina Oxidasa/química , Prolina Oxidasa/aislamiento & purificación , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/aislamiento & purificación , SolubilidadRESUMEN
Epidemiological studies showed that high levels of oxidized low-density lipoproteins (oxLDLs) are associated with increased cancer risk. We examined the direct effect of physiologic concentrations oxLDL on cancer cells. OxLDLs were cytotoxic and activate both apoptosis and autophagy. OxLDLs have ligands for peroxisome proliferator-activated receptor gamma and upregulated proline oxidase (POX) through this nuclear receptor. We identified 7-ketocholesterol (7KC) as a main component responsible for the latter. To elucidate the role of POX in oxLDL-mediated cytotoxicity, we knocked down POX via small interfering RNA and found that this (i) further reduced viability of cancer cells treated with oxLDL; (ii) decreased oxLDL-associated reactive oxygen species generation; (iii) decreased autophagy measured via beclin-1 protein level and light-chain 3 protein (LC3)-I into LC3-II conversion. Using POX-expressing cell model, we established that single POX overexpression was sufficient to activate autophagy. Thus, it led to autophagosomes accumulation and increased conversion of LC3-I into LC3-II. Moreover, beclin-1 gene expression was directly dependent on POX catalytic activity, namely the generation of POX-dependent superoxide. We conclude that POX is critical in the cellular response to the noxious effects of oxLDL by activating protective autophagy.
Asunto(s)
Autofagia/fisiología , Carcinoma/patología , Lipoproteínas LDL/farmacología , Prolina Oxidasa/biosíntesis , Especies Reactivas de Oxígeno/metabolismo , Autofagia/efectos de los fármacos , Carcinoma/metabolismo , Línea Celular Tumoral/efectos de los fármacos , Línea Celular Tumoral/metabolismo , Células Cultivadas/efectos de los fármacos , Células Cultivadas/metabolismo , Células Endoteliales/efectos de los fármacos , Células Endoteliales/metabolismo , Inducción Enzimática/efectos de los fármacos , Femenino , Humanos , Masculino , Malondialdehído/análisis , Proteínas de Neoplasias/antagonistas & inhibidores , Proteínas de Neoplasias/fisiología , PPAR gamma/fisiología , Prolina Oxidasa/antagonistas & inhibidores , Prolina Oxidasa/genética , Prolina Oxidasa/fisiología , Regiones Promotoras Genéticas , Interferencia de ARN , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/fisiología , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis , Regulación hacia Arriba/efectos de los fármacosRESUMEN
Saccharomyces cerevisiae can utilize high quality (e.g. glutamine and ammonia) as well as low quality (e.g. gamma-amino butyric acid and proline) nitrogen sources. The transcriptional activator Put3p allows yeast cells to utilize proline as a nitrogen source through expression of the PUT1 and PUT2 genes. Put3p activates high level transcription of these genes by binding proline directly. However, Put3p also responds to other lower quality nitrogen sources. As nitrogen quality decreases, Put3p exhibits an increase in phosphorylation concurrent with an increase in PUT gene expression. The proline-independent activation of the PUT genes requires both Put3p and the positively acting GATA factors, Gln3p and Gat1p. Conversely, the phosphorylation of Put3p is not dependent on GATA factor activity. Here, we find that the mutation of Put3p at amino acid Tyr-788 modulates the proline-independent activation of PUT1 through Gat1p. The phosphorylation of Put3p appears to influence the association of Gat1p, but not Gln3p, to the PUT1 promoter. Combined, our findings suggest that this may represent a mechanism through which yeast cells rapidly adapt to use proline as a nitrogen source under nitrogen limiting conditions.
Asunto(s)
Antifúngicos/farmacología , Factores de Transcripción GATA/metabolismo , Regulación Fúngica de la Expresión Génica/efectos de los fármacos , Prolina Oxidasa/biosíntesis , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/metabolismo , Sirolimus/farmacología , Factores de Transcripción/metabolismo , Factores de Transcripción GATA/genética , Regulación Fúngica de la Expresión Génica/genética , Mutación , Fosforilación/efectos de los fármacos , Fosforilación/genética , Prolina/genética , Prolina/metabolismo , Prolina Oxidasa/genética , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/genética , Factores de Transcripción/genética , Transcripción Genética/efectos de los fármacos , Transcripción Genética/genéticaRESUMEN
Proline oxidase (POX), a flavoenzyme localized at the inner mitochondrial membrane, catalyzes the first step of proline degradation by converting proline to pyrroline-5-carboxylate (P5C). POX is markedly elevated during p53-induced apoptosis and generates proline-dependent reactive oxygen species (ROS), specifically superoxide radicals, to induce apoptosis through both mitochondrial and death receptor pathways. These previous studies also showed suppression of the mitogen-activated protein kinase pathway leading us to broaden our exploration of proliferative signaling. In our current report, we used DLD-1 colorectal cancer cells stably transfected with the POX gene under the control of a tetracycline-inducible promoter and found that three pathways which cross talk with each other were downregulated by POX: the cyclooxygenase-2 (COX-2) pathway, the epidermal growth factor receptor (EGFR) pathway and the Wnt/beta-catenin pathway. First, POX markedly reduced COX-2 expression, suppressed the production of prostaglandin E2 (PGE(2)) and importantly, the growth inhibition by POX was partially reversed by treatment with PGE(2.) Phosphorylation of EGFR was decreased with POX expression and the addition of EGF partially reversed the POX-dependent downregulation of COX-2. Wnt/beta-catenin signaling was decreased by POX in that phosphorylation of glycogen synthase kinase-3beta (GSK-3beta) was decreased on the one hand and phosphorylation of beta-catenin was increased on the other. There changes led to decreased accumulation of beta-catenin and decreased beta-catenin/TCF/LEF-mediated transcription. Our newly described POX-mediated suppression of proliferative signaling together with the previously reported induction of apoptosis suggested that POX could function as a tumor suppressor. Indeed, in human colorectal tissue samples, immunohistochemically-monitored POX was dramatically decreased in tumors compared with normal counterparts. Thus, POX metabolism of substrate proline affects multiple signaling pathways, modulating both apoptosis and tumor growth, and could be an attractive target to metabolically control the cancer phenotypes.
Asunto(s)
Apoptosis , Neoplasias Colorrectales/enzimología , Ciclooxigenasa 2/metabolismo , Dinoprostona/metabolismo , Proteínas Mitocondriales/biosíntesis , Prolina Oxidasa/biosíntesis , Transducción de Señal , Proteína p53 Supresora de Tumor/metabolismo , Línea Celular Tumoral , Neoplasias Colorrectales/genética , Ciclooxigenasa 2/genética , Regulación hacia Abajo , Receptores ErbB/genética , Receptores ErbB/metabolismo , Regulación Neoplásica de la Expresión Génica , Glucógeno Sintasa Quinasa 3/genética , Glucógeno Sintasa Quinasa 3/metabolismo , Glucógeno Sintasa Quinasa 3 beta , Humanos , Proteínas Mitocondriales/genética , Fosforilación , Prolina/genética , Prolina/metabolismo , Prolina Oxidasa/genética , Especies Reactivas de Oxígeno/metabolismo , Transcripción Genética , Proteína p53 Supresora de Tumor/genética , Proteínas Wnt/genética , Proteínas Wnt/metabolismo , beta Catenina/genética , beta Catenina/metabolismoRESUMEN
Proline oxidase (POX), a mitochondrial inner-membrane protein, catalyzes the rate-limiting oxidation of proline to pyrroline- 5-carboxylate (P5C). Previously we showed that overexpression of POX is associated with generation of reactive oxygen species (ROS) and apoptosis in POX-inducible colorectal cancer cells, DLD-1.POX. We also showed expression of mitochondrial MnSOD partially blunts POX-induced ROS generation and apoptosis. To further investigate the molecular basis of POX-induced apoptosis, we utilized the DLD-1.POX cells to show that cells overproducing POX exhibit an L-proline-dependent apoptotic response. The apoptotic effect is specific for L-proline, detectable at 0.2 mM, maximal at 1 mM, and occurs during 48-72 h following the addition of L-proline to cells with maximally induced POX. The apoptotic response is mitochondria-mediated with release of cytochrome c, activation of caspase-9, chromatin condensation/DNA fragmentation, and cell shrinkage. We conclude that in the presence of proline, high POX activity is sufficient to induce mitochondria-mediated apoptosis.
Asunto(s)
Apoptosis/efectos de los fármacos , Expresión Génica , Mitocondrias/efectos de los fármacos , Mitocondrias/enzimología , Prolina Oxidasa/genética , Prolina/farmacología , Caspasa 9/metabolismo , Línea Celular Tumoral , Citocromos c/metabolismo , Activación Enzimática/efectos de los fármacos , Inducción Enzimática/efectos de los fármacos , Citometría de Flujo , Expresión Génica/efectos de los fármacos , Humanos , Modelos Biológicos , Prolina Oxidasa/biosíntesis , Factores de TiempoRESUMEN
The cAMP receptor protein (CRP) positively regulates the expression of Vibrio vulnificus putAP genes encoding a proline dehydrogenase and a proline permease. In the present study, an open reading frame encoding PutR was identified downstream of the putAP genes and a mutational analysis revealed that the PutR protein was also involved in regulating the putAP transcription by activating Pput promoter. Although CRP acts as a primary activator and the influence of PutR on Pput is mediated by CRP, the level of Pput activity observed when PutR and CRP functioned together was greater than the sum of Pput activities achieved by each activator alone. Western blot analyses demonstrated that the cellular levels of PutR and CRP were not significantly affected by each other, indicating that PutR and CRP coactivate Pput rather than function sequentially in a regulatory cascade. Two adjacent binding sites for PutR mapped by in vitro DNase I protection assays were found to overlap the CRP binding sites and were centred -91.5 (PCBI) and -133.5 bp (PCBII) upstream of the transcription start site of Pput respectively. PutR and CRP bind to the sites cooperatively and a dissection of the role of the binding sites revealed that CRP at PCBI plays the most crucial role in the activation of Pput. Accordingly, the present results revealed that PutR and CRP coactivate the expression of Pput and exert their effect by cooperatively binding to the promoter.
Asunto(s)
Proteínas Bacterianas/metabolismo , Proteína Receptora de AMP Cíclico/metabolismo , Regulación Bacteriana de la Expresión Génica , Operón/genética , Transactivadores/metabolismo , Vibrio vulnificus/genética , Proteínas Bacterianas/genética , Secuencia de Bases , Sitios de Unión , Proteína Receptora de AMP Cíclico/genética , Genes Bacterianos/genética , Datos de Secuencia Molecular , Mutación , Sistemas de Lectura Abierta/genética , Prolina Oxidasa/biosíntesis , Prolina Oxidasa/genética , Regiones Promotoras Genéticas , Transactivadores/genética , Activación Transcripcional , Vibrio vulnificus/metabolismoRESUMEN
The p53-dependent initiation of apoptosis is accompanied by the induction of proline oxidase (POX), a mitochondrial enzyme catalyzing the conversion of proline to pyrroline-5-carboxylate with the concomitant transfer of electrons to cytochrome c. However, the contribution of increased POX activity to apoptosis, if any, remains unknown. Using Adriamycin to initiate p53-dependent apoptosis, we showed that the expression of POX is up-regulated in a time- and dose-dependent manner in a human colon cancer cell line (LoVo). In cells expressing POX, the addition of proline increases reactive oxygen species (ROS) generation in a concentration-dependent manner; glutamate, a downstream product of proline oxidation, had no effect. Induction of POX was dependent on the p53 status of the cell. In the conditionally immortalized murine colonic epithelial cell line YAMC, where the p53 phenotype can be modulated by temperature, proline oxidase expression and ROS production could only be induced when the cells were phenotypically p53-positive. To confirm that the observed ROS production was not secondary to some other effect of p53, we also conditionally expressed POX in a p53-negative colon cancer line. Again, we found a proline-dependent ROS increase with POX expression. We hypothesize that proline oxidation supports the generation of ROS by donating reducing potential to an electron transport chain altered either by p53-dependent mechanisms or by overexpression of POX.
Asunto(s)
Neoplasias del Colon/enzimología , Regulación Neoplásica de la Expresión Génica/fisiología , Prolina Oxidasa/metabolismo , Prolina/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Proteína p53 Supresora de Tumor/fisiología , Antibióticos Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Apoptosis/fisiología , Catálisis , Neoplasias del Colon/genética , Neoplasias del Colon/patología , Doxorrubicina/farmacología , Inducción Enzimática/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Prolina/farmacología , Prolina Oxidasa/biosíntesis , Prolina Oxidasa/genética , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Transfección , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/genética , Regulación hacia Arriba/efectos de los fármacosRESUMEN
Nucleotide sequence of regulatory region (R & R) with putA gene (EMBL Accession No. U39227) from Photobacterium leiognathi PL741 has been determined, and the putA gene encoded amino acid sequence of proline dehydrogenase is deduced. Alignment and comparison of proline dehydrogenase of P. leiognathi with the proline dehydrogenase domain in the PutA protein of Escherichia coli and Salmonella typhimurium show that they are homologous. Nucleotide sequence reveals that regulatory region with the putA gene is linked to the lum and lux operons in genome; the gene order is <--putA--R & R(I)<--ter-lumQ-lumP-R & R-luxC-luxD-luxA-luxB-luxE--> (R & R: regulatory region; ter:transcriptional terminator), whereas the R & R is the regulatory region for the lum and the lux operons, ter is the transcriptional terminator for the lum operon, and R & R(I) apparently is the regulatory region for the putA and related genes. Nucleotide sequence analysis illustrates the specific inverted repeat (SIR), cAMP-CRP consensus sequence, canonical -10/-35 promoter, putative operator and Shine-Dalgarno (SD) sequence on the regulatory region R & R(I) for the putA and related genes; it suggests that the putA and related genes are simply linked to the lum and the lux operons in genome, the regulatory region R & R(I) is independent for the putA and related genes.
Asunto(s)
Proteínas Bacterianas/genética , ADN Bacteriano , Genes Bacterianos , Proteínas de la Membrana/genética , Photobacterium/genética , Prolina Oxidasa/biosíntesis , Prolina Oxidasa/genética , Secuencias Reguladoras de Ácidos Nucleicos , Secuencia de Aminoácidos , Secuencia de Bases , Clonación Molecular , ADN Bacteriano/química , Escherichia coli/enzimología , Cinética , Datos de Secuencia Molecular , Conformación de Ácido Nucleico , Photobacterium/enzimología , Photobacterium/crecimiento & desarrollo , Plásmidos , Prolina Oxidasa/química , Salmonella typhimurium/enzimología , Homología de Secuencia de Aminoácido , Factores de TiempoRESUMEN
The first enzymes of the histidine (hut) and proline degradative pathways, histidase and proline oxidase, could not be induced in Bacillus subtilis cells growing in glucose minimal medium containing a mixture of 16 amino acids. Addition of the 16-amino-acid mixture to induced wild-type cells growing in citrate minimal medium repressed histidase synthesis 25- to 250-fold and proline oxidase synthesis 16-fold. A strain containing a transcriptional fusion of the hut promoter to the beta-galactosidase gene was isolated from a library of Tn917-lacZ transpositions. Examination of histidase and beta-galactosidase expression in extracts of a hut-lacZ fusion strain grown in various media showed that induction, catabolite repression, and amino acid repression of the hut operon were mediated at the level of transcription. This result was confirmed by measurement of the steady-state level of hut RNA in cells grown in various media. Since amino acid repression was not defective in B. subtilis mutants deficient in nitrogen regulation of glutamine synthetase and catabolite repression, amino acid repression appears to be mediated by a system that functions independently of these regulatory systems.
Asunto(s)
Amoníaco-Liasas/genética , Bacillus subtilis/genética , Histidina Amoníaco-Liasa/genética , Histidina/metabolismo , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/genética , Prolina Oxidasa/genética , Prolina/metabolismo , Bacillus subtilis/enzimología , Inducción Enzimática , Genotipo , Histidina Amoníaco-Liasa/biosíntesis , Homeostasis , Mutación , Operón , Plásmidos , Prolina Oxidasa/biosíntesis , Regiones Promotoras Genéticas , Mapeo RestrictivoRESUMEN
L-Proline, which is accumulated by Escherichia coli during growth in media of high osmolality, also induces the synthesis of the enzyme degrading it to glutamate. To determine if proline catabolism is inhibited during osmotic stress, proline utilization and the formation of proline dehydrogenase were examined in varying concentrations of NaCl and sucrose. Although the specific growth rate of E. coli with proline as the sole nitrogen source diminished as the solute osmolality increased, a comparable reduction in growth rate occurred with ammonium as the primary nitrogen source. Proline catabolism, as measured in whole cells by the conversion of [14C]proline to [14C]glutamate, was only slightly inhibited by solute osmolalities up to 1.0 osmol/kg; more than 50% of the initial activity was still found at 2.0 osmol/kg. By contrast, the specific activity of proline dehydrogenase in bacteria grown in the presence of added solutes decreased to less than 20% of the control level. This reduction was related to a lower rate of synthesis, but was independent of genes currently known to be involved in osmoregulation or proline metabolism. The specific activities of tryptophanase, beta-galactosidase, and histidinol dehydrogenase were also reduced under similar growth conditions. These results indicate that while proline catabolism is not directly inhibited by high solute concentrations, prolonged exposure to osmotic stress leads to its reduction as part of a more general metabolic response.
Asunto(s)
Escherichia coli/enzimología , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/biosíntesis , Prolina Oxidasa/biosíntesis , Prolina/metabolismo , Escherichia coli/crecimiento & desarrollo , Cinética , Presión OsmóticaRESUMEN
L-Proline dehydrogenase catalyzes the oxidation of L-proline to delta 1-pyrroline-5-carboxylate, a reaction that is an important step in the utilization of proline as a carbon or nitrogen source by bacteria. A mutant of Escherichia coli K-12 lacking L-leucyl-tRNA:protein transferase had been found previously to contain about five times as much proline dehydrogenase activity as its parent strain. This difference has now been shown to be due to the presence in the parent strain of a previously unrecognized mutation. This mutation, which has been designated put-4977, specifically affects proline dehydrogenase rather than proline uptake. Although proline dehydrogenase remains inducible by L-proline in strains carrying the mutation, there is a premature cessation of differential synthesis during induction that results in a lower specific activity. The mutation shows about 50% P1-mediated cotransduction with pyrC and is therefore located at about 22 min on the E. coli chromosome. Merodiploids containing a normal F' factor still exhibit decreased enzyme activity, indicating that the put-4977 mutation is trans-dominant. The mutation cannot be detected in present stocks of the transferase-deficient mutant, suggesting that this mutant is a revertant for put-4977.
Asunto(s)
Aminoaciltransferasas , Escherichia coli/genética , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/biosíntesis , Prolina Oxidasa/biosíntesis , Aciltransferasas/metabolismo , Mapeo Cromosómico , Cromosomas Bacterianos , Inducción Enzimática , Escherichia coli/enzimología , Escherichia coli/crecimiento & desarrollo , Regulación de la Expresión Génica , Genes Bacterianos , Genes Dominantes , Genes Reguladores , Mutación , Nitrógeno/metabolismo , Fenotipo , Plásmidos , Prolina/metabolismoRESUMEN
1. The site of hydrolysis of rabbit brain endo-oligopeptidase B acting on luteinizing hormone-releasing hormone (LH-RH) was determined by isolating the products by chromatography on Aminex A-5 resin developed with pyridine-acetic acid buffer. The products [des-Gly-NH2(10)]-LH-RH, glycinamide and unhydrolyzed LH-RH were identified and shown to be homogeneous by amino acid analysis and high-voltage paper electrophoresis at pH 2.1 and 3.5 and recovered in yields of 58, 65 and 23%, respectively. 2. A sensitive analytical method for the measurement of 4-40 nmoles of glycinamide with an automatic amino acid analyzer was described. Aminex A-5 resin (0.90 x 15 cm) was eluted with sodium citrate buffer, pH 3.25 (0.2 N Na+) at 32 degrees C and ninhydrin was used for detection. 3. The data show that endo-oligopeptidase B acts as a post-proline cleaving enzyme that inactivates LH-RH by hydrolysis of the Pro9-Gly-NH2(10) peptide bond. The enzyme may participate in the metabolism of LH-RH in the central nervous system.
Asunto(s)
Encéfalo/enzimología , Cisteína Endopeptidasas , Endopeptidasas/metabolismo , Glicina/análogos & derivados , Hormona Liberadora de Gonadotropina/antagonistas & inhibidores , Animales , Cromatografía , Electroforesis en Papel , Glicina/análisis , Hidrólisis , Prolina Oxidasa/biosíntesis , ConejosRESUMEN
The utilization of L-proline as carbon or nitrogen source for the growth of Escherichia coli K12 requires the activities of an L-proline porter (PP-I) and a bifunctional L-proline dehydrogenase-delta1-pyrroline carboxylate dehydrogenase. PP-I is inactivated by mutations at putP and the bifunctional dehydrogenase is encoded in the adjacent locus, putA, at 22 min on the chromosome map. Two additional loci, proP (at 92 min) and proT (at 82 min), have also been implicated in L-proline transport. We have studied four ColE1/E. coli K12 hybrid plasmids from the plasmid bank prepared by Clarke and Carbon. Each of these plasmids was shown previously to complement an L-proline transport defect in E. coli. Genetic complementation analysis and biochemical assays of L-proline transport and L-proline dehydrogenase activity show that three of these hybrid plasmids bear the putPA region of the E. coli chromosome (plasmids pLC4-45, pLC10-29, and pLC43-41). The fourth plasmid, pLC35-38, specifically enhances the L-proline transport activity of its host bacteria but not their L-proline dehydrogenase activity. It probably encodes putP. We have used these plasmids in an E. coli minicell system to identify the putA and putP gene products.
Asunto(s)
Escherichia coli/genética , Amplificación de Genes , Genes , Prolina/metabolismo , Transporte Biológico , Conjugación Genética , Escherichia coli/metabolismo , Prueba de Complementación Genética , Genotipo , Mutación , Fenotipo , Plásmidos , Prolina Oxidasa/biosíntesis , Prolina Oxidasa/genéticaRESUMEN
A mutation resulting in inducer-independent expression of the proline-degradative enzymes was isolated in the yeast Saccharomyces cerevisiae. Strains carrying the mutation, put3, are partially constitutive for proline oxidase and delta 1-pyrroline-5-carboxylate dehydrogenase when grown on a medium lacking proline and are hyperinducible for both enzyme activities when grown on a proline-containing medium. put3 segregates as a single nuclear gene, is not linked to either of the presumed structural genes for proline oxidase and delta 1-pyrroline-5-carboxylate dehydrogenase, and does not affect proline transport. When heterozygous in diploid strains, put3 behaves neither fully dominant nor fully recessive. Endogenous induction by proline has been eliminated as a cause of the inducer-independent enzyme expression in the put3 mutant and the mutation is believed to be in a regulatory component of the proline-degradative pathway.
Asunto(s)
Genes Reguladores , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/biosíntesis , Prolina Oxidasa/biosíntesis , Prolina/metabolismo , Pirrolina Carboxilato Reductasas/biosíntesis , Saccharomyces cerevisiae/genética , Inducción Enzimática , Mutación , Saccharomyces cerevisiae/enzimologíaRESUMEN
Proline is converted to glutamate in the yeast Saccharomyces cerevisiae by the sequential action of two enzymes, proline oxidase and delta 1-pyrroline-5-carboxylate (P5C) dehydrogenase. The levels of these enzymes appear to be controlled by the amount of proline in the cell. The capacity to transport proline is greatest when the cell is grown on poor nitrogen sources, such as proline or urea. Mutants have been isolated which can no longer utilize proline as the sole source of nitrogen. Mutants in put1 are deficient in proline oxidase, and those in put2 lack P5C dehydrogenase. The put1 and put2 mutations are recessive, segregate 2:2 in tetrads, and appear to be unlinked to one another. Proline induces both proline oxidase and P5C dehydrogenase. The arginine-degradative pathway intersects the proline-degradative pathway at P5C. The P5C formed from the breakdown of arginine or ornithine can induce both proline-degradative enzymes by virtue of its conversion to proline.